The design of erodible biomaterials relies on the ability to program the *in vivo* retention time, which necessitates real-time monitoring of erosion. However, *in vivo* performance cannot always be predicted by traditional determination of *in vitro* erosion^[@R1],[@R2]^, and standard methods sacrifice samples or animals^[@R3]^, preventing sequential measures of the same specimen. We harnessed non-invasive fluorescence imaging to sequentially follow *in vivo* material-mass loss in order to model the degradation of materials hydrolytically (PEG:dextran hydrogel) and enzymatically (collagen). Hydrogel erosion rates *in vivo* and *in vitro* correlated, enabling the prediction of *in vivo* erosion of new material formulations from *in vitro* data. Collagen *in vivo* erosion was used to infer physiologic *in vitro* conditions that mimic erosive *in vivo* environments. This approach enables rapid *in vitro* screening of materials, and can be extended to simultaneously determine drug release and material erosion from a drug-eluting scaffold, or cell viability and material fate in tissue-engineering formulations.

Biodegradable materials serve as platforms for structural stabilization, void filling, drug delivery and tissue engineering ^[@R4]--[@R8]^ offering the promise of reduced complications posed by permanent foreign objects.^[@R9]^ Yet, controlled material development is limited as degradation *in vivo* is more complex than *in vitro*, and *in vitro* assays are rarely adequate measures of implant behavior. Loss of material integrity, structure, and eventually mass progress dependently over time but are dominated by different environmental forces *in vitro* and *in vivo*. The question remains as to whether erosion or loss of mass in one domain can predict performance in the other. Gravimetric determinations from periodic sampling of explant weight cannot follow the same formulation over time, necessitate large number of animals to follow small number of samples and have excessive variability.^[@R3],[@R10],[@R11],[@R12],[@R13]^. Chromatography tracks molecular weight changes ^[@R2],[@R12]^ but cannot be applied to eliminable materials that do not undergo chain scission. Material environment affects erosion, and the material and degradation products may affect the environment in turn^[@R14],[@R15]^. Thus, *in vivo* residence times and *in vitro* durability of three dimensional degradable structures differ^[@R2]^.

We developed a noninvasive imaging technique that tracks material erosion *in vivo* through a fluorescent tag covalently attached to components of model materials. Materials erosion was calculated from the decay in total material fluorescence signal using non-invasive In Vivo Imaging System (IVIS). Model hydrolytically degradable adhesive materials used herein are based on polyethylene glycol (PEG) amine and dextran aldehyde^[@R16],[@R17]^. PEG replete with amine groups and oxidized dextran react at body temperature in a Schiff base reaction to form adhesive materials as aldehydes bind to tissue amines. The reaction is reversible and the material hydrolyzes to its polymeric components^[@R16],[@R17]^. Although PEG polymers may undergo enzymatic degradation, significant fluid uptake and swelling dominate the degradation of our formulated PEG:dextran hydrogels, resulting in hydrolytic-sensitive materials. As material shape dictates fluid uptake, we examined whether fluorescence tracking could distinguish the fate of PEG:dextran formulations cast in a series of shapes, sizes and varied PEG solid content. Compressed denatured type II collagen was used as a model for enzymatically degradable material whose erosion profile should change with implantation site and natural variation in enzyme content.

To enable the use of tagged materials to measure erosion rate, we verified that fluorescent tagging had no effect on material properties. Indeed, swelling and erosion kinetics ([Supplementary Figure 1a](#SD1){ref-type="supplementary-material"}), gelation time ([Supplementary Figure 1b](#SD1){ref-type="supplementary-material"}) and adhesion to biological tissues ([Supplementary Figure 1c](#SD1){ref-type="supplementary-material"}) of PEG:dextran were unaffected by 5% fluorescent PEG (demonstrated using the following formulation of dextran, D10-50-14 and PEG, P8-10-40, as described in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). Fluorescent tag tracking however provides different erosion kinetics than conventional wet gravimetric analysis. The two assays demonstrated identical duration of material integrity. Yet, while tag-tracking indicated immediate erosion upon immersion, gravimetric determinations inferred material weight gain until swelling peaked ([supplementary Figure 2](#SD1){ref-type="supplementary-material"}). Indeed, erosion determined by gravimetric analysis was 40% faster than by fluorescent tracking, as the former likely considers elution of media trapped within the network during swelling and not just erosion of polymeric chains. When the effect of swelling is eliminated and gravimetric analysis was performed after samples were dried, the erosion profile coincided with the fluorescent profile ([supplementary Figure 2](#SD1){ref-type="supplementary-material"}), up to the limit of scale sensitivity in the regime where fluorescent quantification remains constantly sensitive. Such drying removes samples from further experimentation and is inappropriate for *in vivo* implants. Fluorescent tracking allows high fidelity identification of polymeric chains released from the bulk gel sequentially from the onset of immersion and without sample destruction.

Hydrophilic material swelling and dissolution is determined by fluid uptake which is modulated by material surface area and the volume of diluent^[@R4]^. We examined material loss profiles in both domains for disks, blocks or hollow mesh cylinders of PEG:dextran (D10-50-14 P8-10-40, [supplementary Figure 3](#SD1){ref-type="supplementary-material"}) all containing 5% fluorescent PEG with fixed mass. Construct erosion *in vivo* was calculated from efficiency signals at the region of interest around the sample ([Figure 1a](#F1){ref-type="fig"}). Erosion was biphasic - comprised of rapid sample loss presumably through diffusion of non-crosslinked, unreacted PEG and dextran polymeric chains, followed by more gradual degradation of the crosslinked copolymer network. In each case, erosion kinetics *in vivo* was faster but tracked with the biphasic behavior seen *in vitro* ([Figure 1b-c](#F1){ref-type="fig"}). Thin blocks and mesh cylinders with significantly higher surface area than the disks showed not unexpectedly accelerated erosion *in vitro* compared with the erosion *in vivo*, leading to exponential dependence of the ratio between *in vivo* and *in vitro* erosion with time ([Figure 1d](#F1){ref-type="fig"}, R= 0.99 for both shapes). In contrast, disk erosion was diluent volume limited and in fixed volume environments *in vivo* erosion kinetics tracked linearly with erosion *in vitro* ([Figure 1d](#F1){ref-type="fig"}, R= 0.98).

Within each hydrogel shape, formulation protocols control erosion profiles as network formation dictates fluid uptake and depends on the aldehyde:amine ratio. As this ratio is determined by the relative amounts of PEG and dextran, we examined the effect of PEG solid content on erosion over a range to the limit of PEG solubility ([Fig. 2a](#F2){ref-type="fig"}). At solid content less than 10 wt%, constructs lose structural integrity; at higher solid content, better stability is observed to a threshold value (above 20 wt%). Each data set adhered to the expected erosion profile and fit a dual exponential decay model. In this model, polymer mass, M, follows the erosion of two components - free (M~1~) and crosslinked (M~2~) material - each defined by relative proportion of total mass, and a specific erosive rate constant, k, at each phase *M* = *M*~1~·*e*^(-*k*~1~*t*)^ + *M*~2~·*e*^(−*k*~2~*t*)^.

The relative measures of the mass components provide an indirect determination of gel content and degree of crosslinking. Though the ratio of unbound and bound rate constants (k~1~/k~2~) spans an order of magnitude with changes in shape, in a fascinating manner the relationship between *in vivo* and *in vitro* ratios is virtually fixed at 2 ([Table S1](#SD1){ref-type="supplementary-material"}), providing a valuable means of assessing erosion in this system. The relative rates of erosion of crosslinked and free material might allow one to infer *in vivo* behavior from *in vitro* performance, and the very acceleration of *in vitro* erosion can be used to predict *in vivo* erosion. As the number of amine groups increases with PEG content, the unbound component drops exponentially ([Fig. 2c](#F2){ref-type="fig"}) but overall erosion is still determined by the rate constant of the bound or crosslinked phase rate (k~2~) ([Fig. 2b](#F2){ref-type="fig"}). Erosion is limited by crosslinking and as the number of amine groups available for gel formation rises, erosion rate drops significantly.

We validated this bi-exponential erosion model and model predictability by prospectively predicting adhesive erosion profiles for newly synthesized PEG:dextran formulations with 10 or 14% PEG solid contents (formulations specified in [Table S2](#SD1){ref-type="supplementary-material"}). Erosive behavior was calculated using values for M~1~, M~2~, k~1~ and k~2~ extracted from the fits of data in [figures 2b-c](#F2){ref-type="fig"} and correlated exceptionally with empiric measures of erosion ([Fig. 2d](#F2){ref-type="fig"}, R = 0.99).

The highest benefit of such model would be the ability to predict *in vivo* erosion kinetics of newly synthesized materials from *in vitro* data. This will minimize the number of animals used and will also serve as a convenient screening platform *in vitro*. Interestingly, *in vivo* erosion ([Figure 3a](#F3){ref-type="fig"}) followed the expected exponential decay and differed with PEG solid content material erosion as seen with disks *in vitro* ([Figure 2a](#F2){ref-type="fig"}), establishing a fixed linear relationship between the *in vitro* and *in vivo* erosion versus time for all formulations ([Figure 3b](#F3){ref-type="fig"}). The ratio of erosion rates in both domains correlates with PEG solid content ([Figure 3c](#F3){ref-type="fig"}). This highly sensitive correlation was used to accurately predict *in vivo* performance based on *in vitro* data for all samples in this formulation type ([Fig. 3d](#F3){ref-type="fig"}, R=0.99). Successful prediction of material erosion demonstrates continuity within the design space and the potential for strategic adjustment of PEG:dextran composition to meet specific requirements.

PEG:dextrans are dominated by hydrolytic erosive forces, other materials are subject to a more complex array of forces which often cannot be reproduced and whose impact is impossible to intuit. Fluorescent tracking enables us to assume that correlation will exist for specific environmental condition set and once attained, to inference that these are the physiologic values. We examined compressed collagen matrices, materials increasingly used in tissue engineering applications and whose degradation requires fluid imbibition, material swelling, enzyme penetration and enzymatic bulk degradation ([Figure 4](#F4){ref-type="fig"}). As with hydrogels, the volume of diluent fluid is critical for erosion, but is increasingly complex in the case of enzymatic degradation. Diffusion of enzymes into samples and of degradation products out requires swelling. Hence, surrounding fluid volume determining degree of swelling should be considered in addition to the classic Michaelis-Menten enzyme kinetics^[@R18]^. Swelling of our collagen-based material is significantly affected by diluent volume with identical enzyme concentration ([Supplementary Figure 4](#SD1){ref-type="supplementary-material"}). While the subcutaneous space of a mouse has a limited fluid volume, the intraperitoneal cavity is significantly larger, with higher volume of fluids. Thus, not unexpectedly erosion kinetics *in vitro* correlated best with *in vivo* behavior for specific immersion volumes that varied with implant site ([Figure 4](#F4){ref-type="fig"}). While *in vitro* erosion under 25μl diluent highly correlated with *in vivo* erosion in the subcutaneous space, linear relationship was obtained for intramuscular and intraperitoneal erosions when 100μl diluent volume was used *in vitro*. In a most intriguing manner the inferred volumes and concentration align remarkably with literature reported empirically-obtained values^[@R19]^.

As with the hydrogels, gravimetric analysis of collagen matrices underestimated erosion early and overestimated erosion late. Sample drying shifted these measures to coincide with fluorescent assays once again verifying the contamination of signal with swelling. The gravimetric analysis, however, was further limited as increasingly sensitive scales would need to be used to track sample weight changes in the regime where fluorescent quantification remains constantly sensitive ([Supplementary Figure 5](#SD1){ref-type="supplementary-material"}).

Tracking material erosion is challenging. *In vivo* performance rarely coincides with erosion *in vitro*. Material fate varies with material dimensions, crosslinking, and composition, and environmental conditions and stresses *in vitro* that do not necessarily represent the *in vivo* state. Pathophysiologic conditions like inflammation cannot be recapitulated *in vitro*. Two questions arise--will erosion *in vivo* follow erosion *in vitro* even if they occur at different rates? And, if there is a match between performances in the two domains, can one be predicted from the other? Indeed, one could use *in vitro* behavior as a surrogate for erosion *in vivo* if such a correlation exits. Here we report that intravital tracking of fluorescent tags on degradable materials can be used similarly *in vivo* and *in vitro*, with a minimum of samples, sequentially on the same specimen, with significant accuracy and most importantly in a correlative fashion. *In vivo* erosion of our selected materials that degrade primarily by hydrolytic or enzymatic degradation correlates with *in vitro* erosion, allowing prediction of the former from the latter. Moreover, erosive materials can be considered like scaffold-tethered drugs^[@R20]^, where erosion kinetics like release kinetics can be successfully modeled with a dual exponent system with free and crosslinked polymer elements like free and bound drug ([Fig. 1](#F1){ref-type="fig"}). Such a system can also now explain the impact of material shape and dimensions, and material formulation protocols on erosion profiles ([Figs. 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}) facilitating the design of materials with programmed retention time. Equally important is that such a system adds great insight into the mechanism of erosion and the physiological conditions that need to be established *in vitro* to attain correlation. We can now explain how and why materials implanted in different target sites, including the subcutaneous, intramuscular and intraperitoneal spaces, resulted in distinctive erosion profiles. While enzymatic degradation of materials *in vivo* is very complex, under the specific set of conditions we have been using, collagen-based material degradation *in vivo* could be recapitulated *in vitro* via variation in fluid volume with physiological enzyme concentrations ([Figure 4a](#F4){ref-type="fig"}). It is remarkable how the definition of the *in vivo* conditions leads to linear correlation between *in vivo* and *in vitro* erosion profiles ([Figure 4b-c](#F4){ref-type="fig"}).

The ability to detect and predict the time course of *in vivo* erosion is crucial to the design and informed regulation and use of increasing number of biomedical devices with erosive properties. While the data published in this manuscript are material and conditions-specific, our approach can be adapted to track the erosion of multiple material systems. Moreover, erosion tracking can be extended beyond the hydrolytic and enzymatic processes examined here to include complex conjugations. Use of multiple tags can enable examination of material dynamics, and even the interaction between molecules using advanced fluorescent methods, such as Fluorescent Resonance Emission Transfer (FRET). The incorporation of multiple concomitant tags allows independent tracking and correlation of drug release and material loss from a polymer drug-eluting scaffold,^[@R21]--[@R23]^ or the fate of cells and materials within tissue engineered formulations.^[@R24],[@R25]^ When tagging is not possible, one could entrap fluorescent molecules e.g., quantum dots, that would serve as surrogate for erosion. It is now possible to follow the fate of erosive materials in a precise and reproducible manner that can be used *in vivo* and *in vitro* and is amenable to mathematical modeling and prospective prediction.

Methods {#S1}
=======

Materials' selection and characterization are described in the [Supplementary Information](#SD1){ref-type="supplementary-material"} {#S2}
-----------------------------------------------------------------------------------------------------------------------------------

### Quantifying material erosion using fluorescent signal *ex-vivo* {#S3}

Mass loss kinetics as measured by gravimetric analysis was compared with erosion profiles obtained by following fluorescent signal loss of labeled materials. To enable erosion detection via optical imaging, PEG was labeled with fluorescein and collagen with Texas Red. Fluorescein labeled PEG was synthesized as follows: 2.4g PEG amine was dissolved in 6 mL dichloromethane. Fluorescein-5-carboxyamido hexanoic acid (Invitrogen) was added to the solution followed by addition of 12 μL triethylamine (Sigma). The mixture was stirred at room temperature for 48 hours. The solid that remained after solvent evaporation was dissolved in 100 mL dd water, dialyzed and lyophilized. PEG solution containing 1% fluorescent PEG was mixed with dextran aldehyde to prepare fluorescent gels. While materials were submerged in 2ml PBS and shaken at 37°C, media was exchanged daily and fluorescence intensity in the media was measured at an excitation wavelength of 485nm and emission wavelength of 538nm. The erosion profile was followed by quantifying the loss of fluorescent signal with time.

Texas Red® labeled collagen was synthesized by reacting the collagen sponges with Texas Red®-T succinimidyl ester (5.6 μl per sponge) in 0.2 M bicarbonate buffer (0.320 ml per sponge), for 2 hours at room temperature. The sponges were rinsed three times in PBS to remove excess unreactive dye.

### Stability of PEG-fluorescein bond {#S4}

To verify that the fluorescent tag remains attached to the polymer materials 1ml PEG-F\* was placed in a dialysis membrane of cellulose ester (Spectra/Por Biotech, MWCO=1000, \#131096) surrounded by 100ml PBS 1x. Free fluorescein could then diffuse out and the media was scanned intermittently at excitation and emission of 485/538nm to quantify the amount of free or detached tag with time.

### Quantifying material erosion using fluorescent signal *in-vivo* {#S5}

Sterile solutions passed through 0.2mm filters were used to prepare PEG:dextran constructs in the shapes of disks, blocks and coated mesh cylinders of the same dimensions as used for *in vitro* evaluation. The constructs were implanted subcutaneously into isoflurane-anesthetized nude albino mice (Charles River Labs) through a 1cm skin incision into the dorsal subcutaneous space of the mice. The incision and pocket were closed with 7-0 prolene sutures.

Sterile collagen based samples, 4 mm in diameter were similarly implanted into the subcutaneous space of a mouse (SC), intraperitoneally (IP) and intramuscularly (IM). Immediately and at various intervals after surgery, the animals were imaged using the Xenogen IVIS device using the relevant filter sets. Fluorescence intensity was determined by calculating the efficiency overlying each construct where the fluorescent intensity is corrected to eliminate tissue autofluorescence. While fluorescein was used for SC implantations, Texas Red was used for deeper target sites (IM and IP) to avoid photo bleaching and light penetration issues. The choice of fluorescent dye is critical, especially when tracking materials for extended period of times. Optimal dyes are near-IR dyes that do not undergo photobleaching during the experimental period and do not overlap with tissue autofluorescence.

### Statistical Analyses {#S6}

Data are presented as mean ± standard deviation unless otherwise indicated (n = 3 for *in vitro* swelling and degradation, adhesion and gelation time of PEG-dextran formulations, n=5 for *in vitro* erosion characterization of collagen based samples, n=5 and 10 for *in vivo* erosion tracking of PEG:dextran and collagen based formulations, respectively). To take multiple comparisons into account, when comparing swelling and degradation, statistical comparisons were done using two way ANOVA with replication. A P-value \<0.05 was considered to denote statistical significance.
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![I*n vitro -- in vivo* correlation of PEG:dextran erosion profiles exists and varies with material surface area\
*In vitro* and *in vivo* erosion profiles of PEG-dextran (D10-50-14 P8-10-40) cast in a series of shapes are depicted by tracking the loss of fluorescence intensity with time. The effect of material shape on degradation profile was followed *in vivo* noninvasively in the dorsal subcutaneous space of the mouse (disk shaped materials are presented) (a), and *in vitro* (b). The loss of fluorescent signal with time *in vivo* was converted to weight loss (c) and correlated with the *in vitro* loss (d). An excellent correlation was found between mean values of *in vitro* and *in vivo* erosions of disk $\frac{In - \mathit{vitro}}{In - \mathit{vivo}_{\mathit{disk}}} = 0.033t + 0.93$; (R= 0.96), block $\frac{In - \mathit{vitro}}{In - \mathit{vivo}_{\mathit{block}}} = 0.928 \cdot \exp(0.27 \cdot t)$; (R= 0.94), and mesh cylinder $\frac{In - \mathit{vitro}}{In - \mathit{vivo}_{\mathit{mesh}}} = 0.934 \cdot \exp(0.032 \cdot t)$; (R= 0.98). Disk erosion *in vivo* tracked linearly with erosion *in vitro* (Figure 1d, R= 0.98). Thin blocks and mesh cylinders with significantly higher surface area than the disks (116, 190 and 86mm^2^ respectively) showed accelerated erosion *in vitro* compared with the erosion *in vivo*, leading to exponential dependence of the ratio between *in vivo* and *in vitro* erosion with time (Figure 1d, R= 0.99 for both shapes).](nihms310884f1){#F1}

![Dual exponential decay model describes PEG:dextran *in vitro* erosion and enables prospective prediction of erosion profile of new material formulations. Alteration of PEG solid content from 10 to 29wt% enables fine-tuning of material erosion kinetics (a). Model descriptors are presented as a function of PEG solid content. While k~1~ is constant and k~2~ decays exponentially (b); M~1~ and M~2~ similarly demonstrate reciprocal exponential changes with PEG solid content (c). The relationships between model descriptors and PEG solid content (PEG~SC~) are as follows: $$\begin{array}{l}
{k_{2} = 53.7 \cdot \exp( - 0.88 \cdot (\mathit{PEG}_{SC})) + 0.0009,} \\
{M_{1} = 3979 \cdot \exp( - 0.44 \cdot (\mathit{PEG}_{SC})) + 12.4\mspace{7mu}\text{and}} \\
{M_{2} = - 3028 \cdot (1 - \exp( - 0.41 \cdot (\mathit{PEG}_{SC})) + 85.4.} \\
\end{array}$$ Using the equations describing the relation between model descriptors and PEG solid content, the erosion profile of new compositions containing 10 and 14wt% PEG were prospectively predicted (points are empirically accumulated and lines are model predictions) (d). Constants were extrapolated from the data fits and are inserted in the figures as blue symbols, while squares represent k~1~ and M~1~ and circles represent k~2~ and M~2~. Predicted erosion correlated well with empiric observations (Pearson's coefficient R= 0.99).](nihms310884f2){#F2}

![*In vitro-- in vivo* correlation of PEG:dextran erosion profiles enables prediction of *in vivo* erosion kinetics from *in vitro* data\
*In vivo* erosion of PEG-dextran formulations is depicted and follows the trend of the *in vitro* erosion profile, at a faster pace, as demonstrated for compositions with 10, 14, 20 or 29wt% PEG solid content (a). A linear relationship exists between the ratio of *in vivo* and *in vitro* erosion as a function of time for all PEG solid contents examined (b). The slopes of these curves linearly correlate with PEG solid content (c). Using this linear relationship, *in vivo* erosion profiles of two different formulations were accurately predicted from *in vitro* data (R=0.99) (points are empirically accumulated and lines are model predictions) (d).](nihms310884f3){#F3}

![*In vivo* erosion profile is site-dependant and can be used to infer physiologically relevant *in vitro* conditions for enzymatic materials\
*In vitro* and *in vivo* erosion of compressed denatured type II collagen are presented. *In vivo* erosion at target sites that differ in enzyme concentration and fluid volume (Subcutaneous (SC), intraperitoneal (IP) and intramuscular (IM)) is site dependent and fits one exponential decay model *(R=0.44, 0.77, and 0.7 for SC, IP and IM)* (a). The *in vivo* erosion profiles were used to infer physiologically relevant conditions of diluent volume and enzyme concentration. While *in vitro* erosion depends both on enzyme concentration and fluid volume, a specific set of conditions resulted in an *in vitro* erosion profile *(R=0.71, 0.9, and 0.95 for SC, IP and IM)* (b) that linearly correlates with the *in vivo* erosion (c). The erosion in both domains fit an exponential decay model. A correlation between the erosion profiles *in vitro* and *in vivo* is achieved when SC implantation is plotted versus *in vitro* erosion of material submerged in 25μl of PBS solution containing physiological concentration of collagenase, and for IM and IP implantations when compared with *in vitro* erosion using 100μl of PBS containing enzyme solution. Linear correlation between *in vitro* and *in vivo* erosion enables screening of materials *in vitro* with *in vivo* prediction capacity.](nihms310884f4){#F4}
